Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Celularity Inc in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Naveen Jain, Director (Form 8-K filed 2026-09-29). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Philip & Daniele Barach Family Trust (filed 2026-09-28).
Who is behind it
Celularity Inc: incorporated in Delaware; business address in Florham Park, New Jersey; industry Pharmaceutical Preparations (Form D, 2026-09-29).
Officers and directors, each with the role and the filing that names them:
- Robert J. Hariri: Executive Officer, Director (Form D, 2025-11-03)
- John R. Haines: Executive Officer (Form D, 2025-11-03)
- Joseph DosSantos: Executive Officer (Form D, 2025-11-03)
- Stephen A. Brigido: Executive Officer (Form D, 2025-11-03)
- Peter Diamandis: Director (Form D, 2025-11-03)
- Vincent LeVien: Director (Form D, 2025-11-03)
- Geoffrey Ling: Director (Form D, 2025-11-03)
- Diane Parks: Director (Form D, 2025-11-03)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-09-28 | Philip & Daniele Barach Family Trust | 29% |
| Schedule 13D/A, 2026-06-23 | Philip & Daniele Barach Family Trust | 15.8% |
| Schedule 13D/A, 2026-04-22 | Philip & Daniele Barach Family Trust | 20.1% |
| Schedule 13D, 2026-04-03 | Philp & Daniele Barach Family Trust | 9.56% |
| Schedule 13G/A, 2026-02-11 | Lincoln Alternative Strategies LLC | 0% |
| Schedule 13G, 2025-08-27 | Lincoln Alternative Strategies LLC | 5.14% |
| Schedule 13D/A, 2025-07-28 | Dragasac Limited | 41% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-29 | Naveen Jain | Director | appointed | |
| Form 8-K, 2026-09-29 | Naveen Jain | appointed | ||
| Form 8-K, 2026-09-29 | Diane Parks | departed | ||
| Form 8-K, 2026-09-28 | Philip A. Barach | Director | appointed | 2026-09-24 |
| Form 8-K, 2026-09-28 | Philip A. Barach | appointed | ||
| Form 8-K, 2026-08-07 | Rick Gonzalez | Chief Commercial Officer | departed | |
| Form 8-K, 2026-06-25 | Steven N. Gordon | Chief Operating and Administrative Officer | appointed | |
| Form 8-K, 2026-06-25 | K. Harold Fletcher | Chief Legal and Strategy Officer | appointed | 2026-06-19 |
| Form 8-K, 2026-06-25 | Steven N. Gordon | Director | appointed | 2026-06-19 |
| Form 8-K, 2026-06-03 | Rick Gonzalez | Chief Commercial Officer | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-11-03 | $2M | $6.67M |
| Form D, 2025-08-05 | $1.03M | $1.03M |
| Form D, 2025-08-05 | $6.81M | $6.81M |
| Form D, 2025-08-05 | $2M | $2M |
Latest IPO step: Celularity Inc filed to go public (S-1, 2025-12-31).
IPO filings: S-1, 2025-12-31, S-1, 2025-12-19, RW, 2025-03-10, S-1/A, 2025-02-13, S-1, 2025-01-30; ticker CELU on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/celularityLast updated 2026-10-18
Primary record: Schedule 13D/A, 2026-09-28 · Form D, 2025-11-03 · Form 8-K, 2026-09-29 · Form 8-K, 2026-09-28
Who owns Celularity Inc? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/celularity